European Union regulators revealed on Thursday that Samsung Electronics is not willing to drag its rivals, like Apple, to court over patent disputes so as to end an antitrust investigation. The move is likely to end a feud between the world's biggest mobile operators. Samsung is also likely to be benefitted from the move by averting a possible fine of up to $18.3 billion.
It is a known fact that a long-running war exists between Samsung and Apple in courts in more than 10 countries. The reason is simple, both wants to gain control of the lucrative mobile market.
"Samsung has offered to abstain from seeking injunctions for mobile SEPs (standard essential patents) for a period of five years against any company that agrees to a particular licensing framework", the Commission said in a statement.
Interested parties can comment on Samsung's proposal within a month, it said. The commission was of the belief that clarity will be brought to the mobile telephony industry via the Samsung case.
Joaquin Almunia, the European Commissioner for Competition, said that standard-essential patent abuses must be taken care of to ensure standard-setting are not adversely affected and customers do not have to pay the price for so-called patent wars.
In a recent announcement, Amazon has revealed that it has rolled out an update to its Echo digital assistant, to ensure that organizing plans and schedules becomes much more convenient for Echo users.
The update to the Amazon Echo wireless...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
In a Friday announcement, Fiat Chrysler said that it is recalling nearly 1.1 million vehicles due to a transmission shifter issue. The automaker said that the problem which has resulted in the recall can cause the affected vehicles to roll away...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In an announcement made via a blog post on Thursday,...
In a Friday announcement, Fiat Chrysler said that it is...
In a recent announcement, Sega has revealed that its...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).